Clinical Trial Update: THOR - Tübingen Choroideremia Gene Therapy Trial [Phase 2]

View source ↗

Summary

Phase 2 gene therapy trial for choroideremia completed, updating on THOR study in Tübingen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choroideremia

Drugs mentioned

• THOR

Snippet

Sponsor: STZ eyetrial | Conditions: Choroideremia | Phase 2 | Status: COMPLETED